Mr. Mucus gets a new home

Share this article:

Mr. Mucus is going to work for Reckitt Benckiser, which bought Adams Respiratory Therapeutics, maker of the heavily advertised Mucinex franchise, for $2.3 billion. Though better known for its household cleaning products, Reckitt makes opiate dependency treatment Suboxone and recently bought two OTC meds from Boots. 

Share this article:

Email Newsletters

More in News

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.

Shire, AbbVie join forces for $55B

Shire, AbbVie join forces for $55B

The deal includes a $1.6-billion fee if AbbVie tries to walk away.

Next target for hep. C drugmakers: co-infections

Next target for hep. C drugmakers: co-infections

An international AIDS conference this weekend kicked off a new battle in the war against hepatitis C: demonstrating high cure rates in those who are co-infected.